JelloX Aims to Improve Patient-Centered Care with AI-powered 3D Digital Pathology

First shared at a recent Japanese Society of Digital Pathology meeting, the company is forging a global alliance with a leading US medical institution and other organizations to harness technology for better patient care and outcomes in oncology. JelloXBiotech Inc., aTaiwan-based startup focused on cancer pathology, is unveiling its vision for AI and 3D digital […]

1E Announces Continued Profitable Growth and 2024 Results

Digital Employee Experience (DEX) Leader Achieved Multiple Milestones and 30% Global ARR Growth LONDON, UK, AND AUSTIN, TX / ACCESSWIRE / January 22, 2025 / 1E, a leading Digital Employee Experience (DEX) platform company known for its scaled remediation and automation capabilities, today announced its 2024 results1. 1E exited 2024 with $79.3 million ARR. The

DEWALT® Lights Up Vegas Skyline with Innovative Drone-Powered Sphere Activation; Celebrates Concrete Construction Crews with New “Built for the Unbreakable” Campaign

— DEWALT once again transforms the Las Vegas skyline with an electrifying activation on the exterior of Sphere — Unveils new “Built for the Unbreakable” campaign celebrating the strength of the men and women who work in the construction trades — Spotlights award-winning DEWALT POWERSHIFT™ System, a groundbreaking equipment system that optimizes the workflow of

Vallourec reduces its carbon footprint by 19% in 4 years

(Paris:VK), VALLOUREC REDUCES ITS CARBON FOOTPRINT BY 19% IN 4 YEARS Meudon (France), January 22nd, 2025 – Vallourec, a world leader in premium seamless tubular solutions, announces the result of its seamless tubes carbon footprint life cycle assessment. Based on 2023 data, Vallourec has reduced its carbon footprint to 1.45 tonnes of CO2 equivalent per

Relief Therapeutics Completes Strategic Transition with Sale of GOLIKE Rights ex-US

Sale of GOLIKE® Rights Outside the U.S. to NutrisensRelief to Focus on R&D of Pipeline Assets and Licensing for Commercialized Products GENEVA, SWITZERLAND / ACCESSWIRE / January 22, 2025 / RELIEF THERAPEUTICS Holding SA(SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (Relief, or the Company), a biopharmaceutical company committed to delivering innovative treatment options for select specialty, unmet and rare diseases, today

Vallourec reduces its carbon footprint by 19% in 4 years

Vallourec reduces its carbon footprint by 19% in 4 years GlobeNewswire January 22, 2025 VALLOUREC REDUCES ITS CARBON FOOTPRINT BY 19% IN 4 YEARS Meudon (France), January 22nd, 2025 – Vallourec, a world leader in premium seamless tubular solutions, announces the result of its seamless tubes carbon footprint life cycle assessment. Based on 2023 data,

Education Market in the UAE to Grow by USD 5.1 Billion (2025-2029), Driven by Rising Student Enrollments, Report Highlights How AI Redefines the Landscape – Technavio

Report with market evolution powered by AI – The education market in UAEsize is estimated to grow by USD 5.1 billion from 2025-2029, according to Technavio. The market is estimated to grow at a CAGR of 8.6% during the forecast period. Increasing student enrollmentsis driving market growth,with a trend towardsrising awareness of early education. However,increased

ROHM’s Second-generation MUS-IC (TM) Series Audio DAC Chip for Hi-res Audio Playback with Exclusive HD Monaural Mode

Delivers Authentic Listening Experience by Expressing Three Elements of Spatial Reverberation, Quietness, and Dynamic Range While Preserving Natural “Texture” of Musical Instruments – ROHM has developed a 32-bit D/A converter IC (DAC chip) and an evaluation board for flagship models in its MUS-IC (TM) series, optimized for high-resolution audio playback. DAC chips are key to

Press Release: Sarclisa approved in the EU as the first anti-CD38 therapy in combination with standard-of-care VRd to treat transplant-ineligible newly diagnosed multiple myeloma

(Paris:SAN), Sarclisa approved in the EU as the first anti-CD38 therapy in combination with standard-of-care VRd to treat transplant-ineligible newly diagnosed multiple myeloma Approval is based on positive results from the IMROZ phase 3 study, demonstrating Sarclisa in combination with standard-of-care treatment significantly improved PFS, compared to the standard of care alone in TI NDMM

Patrik Hammaren appointed as President of Nokia Technologies

(Helsinki:NOKIA),(Irish:IRSH),(LSE:0HAF),(Paris:NOKIA), Nokia Corporation Stock Exchange Release22 January 2025 at 08:00 EET Patrik Hammaren appointed as President of Nokia Technologies Patrik Hammaren appointed as President of Nokia Technologies and member of the Nokia Group Leadership Team Espoo, Finland – Nokia today announced the appointment of Patrik Hammaren as President of Nokia Technologies and member of the

Scroll to Top